{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"5404006d-851f-4809-b506-06ab5502d222","metadata_created":"2019-01-21T15:51:28.499201","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2019-01-21T15:51:28.499210","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2019-01-21","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["VIH","L’hépatite C","tuberculose au Canada","Le virus Zika","Zika et la microcéphalie","l’infection chronique","traitement du virus Zika."],"en":["HIV in Canada","Canadians with HIVm long-term HIV care","Hepatitis C","risk-based screening","tuberculosis","tuberculosis primary care","Zika virus","flavivirus","Central America","microcephaly","chronic hepatitis C virus infection","recommendations on Zika virus"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 42-3, le 3 mars 2016 : Maladie infectieuse chronique","en":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"55ca9e28-9430-4c67-931c-645fc683e9ea","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-3, le 3 mars 2016 : Maladie infectieuse chronique","en":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease","language":["en"],"created":"2019-01-21T15:51:29.180085","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016.html","last_modified":null,"position":0,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8654c1a4-463a-4a94-abce-b8844cdb6da3","related_relationship":"","name_translated":{"fr":"RMTC : Volume 42-3, le 3 mars 2016 : Maladie infectieuse chronique","en":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease","language":["fr"],"created":"2019-01-21T15:51:29.180095","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016.html","last_modified":null,"position":1,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"id":"e0bda7d7-616d-4e49-972e-b620c6bc6890","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-3, le 3 mars 2016 : Maladie infectieuse chronique","en":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease","language":["en"],"created":"2019-01-21T15:51:29.180098","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-3/assets/pdf/16vol42_3-eng.pdf","last_modified":null,"position":2,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"id":"9fe59297-fb9f-4585-bd96-84b50156ed41","character_set":"","state":"active","name_translated":{"fr":"RMTC : Volume 42-3, le 3 mars 2016 : Maladie infectieuse chronique","en":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease","language":["fr"],"created":"2019-01-21T15:51:29.180100","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/16vol42/dr-rm42-3/assets/pdf/16vol42_3-fra.pdf","last_modified":null,"position":3,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"bfdd9109-45ba-4bb5-a0d5-2b9c2686226f","related_relationship":"","name_translated":{"fr":"Comparaison des besoins en soins de santé des personnes vivant avec, et sans, le VIH dans le contexte des soins à domicile et des soins de longue durée au Canada","en":"Comparing the care needs of people living with and without HIV in Canadian home and long-term care settings"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Comparing the care needs of people living with and without HIV in Canadian home and long-term care settings","language":["en"],"created":"2019-01-21T15:51:29.180103","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016/ccdr-volume-42-3-march-3-2016-infectious-disease-chronic-disease.html","last_modified":null,"position":4,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"253411a9-9c77-4c96-90c1-4859e9ec195a","related_relationship":"","name_translated":{"fr":"Comparaison des besoins en soins de santé des personnes vivant avec, et sans, le VIH dans le contexte des soins à domicile et des soins de longue durée au Canada","en":"Comparing the care needs of people living with and without HIV in Canadian home and long-term care settings"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Comparing the care needs of people living with and without HIV in Canadian home and long-term care settings","language":["fr"],"created":"2019-01-21T15:51:29.180105","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique.html","last_modified":null,"position":5,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"15be8182-f43b-4ddb-9156-b63a13ec6794","related_relationship":"","name_translated":{"fr":"L’hépatite C au Canada et l’importance du dépistage fondé sur les risques","en":"Hepatitis C in Canada and the importance of risk-based screening"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Hepatitis C in Canada and the importance of risk-based screening","language":["en"],"created":"2019-01-21T15:51:29.180108","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016/ccdr-volume-42-3-march-3-2016-infectious-disease-chronic-disease-1.html","last_modified":null,"position":6,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"37061c41-6322-4348-a13b-82217867b1cd","related_relationship":"","name_translated":{"fr":"L’hépatite C au Canada et l’importance du dépistage fondé sur les risques","en":"Hepatitis C in Canada and the importance of risk-based screening"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Hepatitis C in Canada and the importance of risk-based screening","language":["fr"],"created":"2019-01-21T15:51:29.180111","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique-1.html","last_modified":null,"position":7,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"934be939-a31f-42eb-a513-d09948c39541","related_relationship":"","name_translated":{"fr":"Principaux conseils cliniques en matière de soins primaires pour participer à l’élimination de la tuberculose au Canada","en":"Primary care pearls to help eliminate tuberculosis in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Primary care pearls to help eliminate tuberculosis in Canada","language":["en"],"created":"2019-01-21T15:51:29.180113","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016/ccdr-volume-42-3-march-3-2016-infectious-disease-chronic-disease-2.html","last_modified":null,"position":8,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9a1681bb-585d-4c9b-b36c-d7ebccd7ed8c","related_relationship":"","name_translated":{"fr":"Principaux conseils cliniques en matière de soins primaires pour participer à l’élimination de la tuberculose au Canada","en":"Primary care pearls to help eliminate tuberculosis in Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Primary care pearls to help eliminate tuberculosis in Canada","language":["fr"],"created":"2019-01-21T15:51:29.180116","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique-2.html","last_modified":null,"position":9,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"5e4d4383-e212-4f9f-834c-b36748fec330","related_relationship":"","name_translated":{"fr":"Le virus Zika, un flavivirus émergent, identifié comme cause de fièvre et d’éruption cutanée chez un voyageur de retour d’Amérique centrale","en":"Zika virus, an emerging flavivirus, as a cause of fever and rash in a traveller returning from Central America"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Zika virus, an emerging flavivirus, as a cause of fever and rash in a traveller returning from Central America","language":["en"],"created":"2019-01-21T15:51:29.180118","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016/ccdr-volume-42-3-march-3-2016-infectious-disease-chronic-disease-3.html","last_modified":null,"position":10,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"46f0d547-49b8-425c-a5d3-c45356316a7b","related_relationship":"","name_translated":{"fr":"Le virus Zika, un flavivirus émergent, identifié comme cause de fièvre et d’éruption cutanée chez un voyageur de retour d’Amérique centrale","en":"Zika virus, an emerging flavivirus, as a cause of fever and rash in a traveller returning from Central America"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Zika virus, an emerging flavivirus, as a cause of fever and rash in a traveller returning from Central America","language":["fr"],"created":"2019-01-21T15:51:29.180121","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique-3.html","last_modified":null,"position":11,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"dfe17b5c-9cb9-4671-bf46-9b0ff5d9b199","related_relationship":"","name_translated":{"fr":"Lien entre le virus Zika et la microcéphalie","en":"Zika virus associated with microcephaly"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Zika virus associated with microcephaly","language":["en"],"created":"2019-01-21T15:51:29.180123","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-3-march-3-2016/ccdr-volume-42-3-march-3-2016-infectious-disease-chronic-disease-4.html#a1","last_modified":null,"position":12,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6360b1a9-0068-4a64-b922-3783dacdcc31","related_relationship":"","name_translated":{"fr":"Lien entre le virus Zika et la microcéphalie","en":"Zika virus associated with microcephaly"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Zika virus associated with microcephaly","language":["fr"],"created":"2019-01-21T15:51:29.180125","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique-4.html#a1","last_modified":null,"position":13,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"caf0ec7c-249b-4cb9-a8e6-55836cd4c284","related_relationship":"","name_translated":{"fr":"Manifestations extrahépatiques associées à l’infection chronique par le virus de l’hépatite C","en":"Extrahepatic manifestations of chronic hepatitis C virus infection"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Extrahepatic manifestations of chronic hepatitis C virus infection","language":["fr"],"created":"2019-01-21T15:51:29.180128","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-3-3-mars-2016/rmtc-volume-42-3-3-mars-2016-maladie-infectieuse-chronique-4.html#a2","last_modified":null,"position":14,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"027fc04f-c776-4a2c-a5d0-d9a4c7362019","related_relationship":"","name_translated":{"fr":" Recommandations canadiennes pour la prévention et le traitement du virus Zika.","en":" Recommendations on the Prevention and Treatment of Zika Virus."},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Recommendations on the Prevention and Treatment of Zika Virus.","language":["en"],"created":"2019-01-21T15:51:29.180130","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2016-42/ccdr-volume-42-5-may-5-2016/ccdr-volume-42-5-may-5-2016-zika-virus.html","last_modified":null,"position":15,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"5404006d-851f-4809-b506-06ab5502d222","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c80e5407-1ce1-4dc7-8273-7d62205bf2b1","related_relationship":"","name_translated":{"fr":" Recommandations canadiennes pour la prévention et le traitement du virus Zika.","en":" Recommendations on the Prevention and Treatment of Zika Virus."},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":" Recommendations on the Prevention and Treatment of Zika Virus.","language":["fr"],"created":"2019-01-21T15:51:29.180133","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2016-42/rmtc-volume-42-5-5-mai-2016/rmtc-volume-42-5-5-mai-2016-virus-zika.html","last_modified":null,"position":16,"revision_id":"5f881a42-252a-459c-802a-620248601457","resource_type":"website"}],"place_of_publication":[],"num_resources":17,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2016-03-03 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"5404006d-851f-4809-b506-06ab5502d222","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 42-3, March 3, 2016: Infectious Disease as Chronic Disease","revision_id":"5f881a42-252a-459c-802a-620248601457"}